Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity
2011

Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity

publication Evidence: high

Author Information

Author(s): Akunuru Shailaja, Palumbo Joseph, Zhai Qihui James, Zheng Yi

Primary Institution: University of Cincinnati

Hypothesis

Rac1 is critical for tumor initiation and metastasis of human non-small cell lung adenocarcinoma (NSCLA).

Conclusion

Targeting Rac1 may have therapeutic value in suppressing cancer stem cell proliferation and metastasis in lung cancer.

Supporting Evidence

  • Rac1 knockdown reduced proliferation and colony formation in lung cancer cells.
  • Rac1 targeting decreased adhesion, migration, and invasion of NSCLA cells.
  • Rac1 knockdown prevented lung colonization of NSCLA cells in mice.
  • Side population cells exhibited elevated Rac1 activity and increased tumorigenic potential.

Takeaway

Rac1 is like a switch that helps cancer cells grow and spread. Turning it off can stop these bad cells from causing more trouble.

Methodology

The study involved knocking down Rac1 in lung cancer cell lines and primary patient specimens, followed by various assays to assess tumorigenic activities.

Limitations

The study may not account for all cancer stem cell populations, as CSCs can be dynamic and inter-convertible.

Participant Demographics

The study involved human non-small cell lung adenocarcinoma cell lines and primary patient samples.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016951

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication